focus -WSS

focus

author：leisure time 2025-10-04 08:32:31 - browse：81

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Sanders adds drug shortage policies to pandemic preparedness bill

focus

explore

WSS

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

STAT Virtual Event: The State of Biosimilars: What to Watch

Virtual repurposing can help discover new uses for existing drugs

Are embryos people? Reproductive medicine's future depends on the answer

Color Health wants to make cancer screenings convenient

WHO calls for emergency meeting on new China virus, as cases spread

Wikipedia

focus

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Group opposing PBM reform sets lobbying record

United colonoscopy coverage change 'may cost lives,' doctors say

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Duchenne breakthrough therapy leaves behind pioneering families

Startup Neumora takes a novel depression drug to Phase 3

Dobbs anniversary: the lost opportunity of abortion as health care

As digital health tech proliferates, a new institute aims to cut through hype

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ohio train derailment: Experts on toxic chemical risks

entertainment

Childhood vaccination ad campaign launches in the U.K.

Startup Neumora takes a novel depression drug to Phase 3

AI can’t replace a physician’s gut feeling

Pfizer is about to make a big push in cancer. Will investors listen?

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Medicare isn't yet testing food as medicine

entertainment

focus

explore

entertainment